Where does AbVitro LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AbVitro LLC ranks #18,337 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AbVitro LLC hold?

AbVitro LLC holds 15 US utility patents granted between 2017 and 2024, spanning 7 technology areas.

What is AbVitro LLC's Innovation Score?

AbVitro LLC has an Innovation Score of 35.9 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is AbVitro LLC's patent grant rate increasing or decreasing?

AbVitro LLC's recent grant velocity is +175% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for AbVitro LLC's patents?

AbVitro LLC's patents average 25.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AbVitro LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

AbVitro LLC

Q: What technology areas does AbVitro LLC focus on?

AbVitro LLC's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 13 patents, ranking #809 of 4,144 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abvitro ranks #18,337 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.

#18,337
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.9/100): 25.9
avg claims per patent: +175%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18337 · US Corporation #18,337 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,337/49,997
PHOTO-FINISH AbbVie S á r l
CPC-NARROW C12N · 7 areas
INNOV-THIN 35.9/100
CLAIMS-DENSE 25.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +175% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AbbVie S.á.r.l. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abvitro’s 35.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (27%) Velocity 2.0 pts (6%) Breadth 9.4 pts (26%) Claim depth 15.0 pts (42%)

Qualcomm Incorporated · highest

85
AbVitro · this assignee

36
Mcginley Engineered… · near

36
Naver Business… · near

36
New BIS Safe Luxco… · near

36
Zhongying Changjiang… · near

36
3D Lighting… · lowest

7

What this shows Abvitro's Innovation Score is 35.9/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abvitro?

Each dot is one of Abvitro’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abvitro’s own 25.9 claims/patent is ABOVE the 18.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abvitro vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abvitro's grants concentrate

AbVitro LLC is a focused PatentsView assignee: 7 CPC subclasses with 86.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2017. By volume, Abvitro sits between AVK Holding A/S and Actian Corporation.

Abvitro's three-year grant acceleration

AbVitro LLC shows 3 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

AVK Holding A/S

15
Axon Therapies

15
Ayrton

15
Azotek

15
Abbvie S á r l

15
Accu Temp Products

15
Actlight

15
Actian

15
Abvitro ◀

15

What this shows AbVitro holds 15 patents at rank #18,377, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AbVitro

By rank, the assignees closest to #18,377 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in AbVitro's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for AbVitro, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), AbVitro ranks #809 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Naver Business Platform Corporation 36 New BIS Safe Luxco S.à r.l 36 Zhongying Changjiang International NEW Energy Investment Co., Ltd. 36 Mcginley Engineered Solutions, LLC 36

Abvitro's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

AbVitro LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	6.7%
2018	1	6.7%
2019	2	13.3%
2020	2	13.3%
2021	6	40.0%
2023	1	6.7%
2024	2	13.3%

Which technologies does AbVitro LLC patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C07K - Peptides 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AbVitro LLC's patent record in context - here's where to go next.

AbVitro LLC's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 86.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #18,337 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AbVitro LLC against AVK Holding A/S, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.